Neogenomics Inc NEO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:02 PM EST
48.43UNCH (UNCH)
Volume
9,584
Close
48.43quote price arrow down-3.16 (-6.13%)
Volume
897,282
52 week range
20.47 - 61.57

...

Loading . . .

KEY STATS

  • Open52.00
  • Day High52.00
  • Day Low48.09
  • Prev Close51.59
  • 52 Week High61.57
  • 52 Week High Date02/16/21
  • 52 Week Low20.47
  • 52 Week Low Date03/12/20
  • Market Cap5.663B
  • Shares Out116.94M
  • 10 Day Average Volume0.79M
  • Dividend-
  • Dividend Yield-
  • Beta0.72
  • 1 Year % Change61.76

RATIOS/PROFITABILITY

  • EPS (TTM)0.03
  • P/E (TTM)1,513.44
  • Fwd P/E (NTM)288.27
  • EBITDA (MRQ)16.275M
  • ROE (MRQ)0.69%
  • Revenue (MRQ)444.45M
  • Gross Margin (MRQ)41.83%
  • Net Margin (MRQ)0.94%
  • Debt To Equity (MRQ)24.76%

EVENTS

  • Earnings Date04/26/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Neogenomics Inc News

There is no recent news for this security.

Latest NEO News From Our Partners

QUOTE FINDER

Profile

MORE
NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. This segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. It has laboratory locations in Ft. Myers and Tampa, Florida; Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Houston, Texas and Nashville, and Tennessee. It offers testing services, which include...
Douglas VanOort
Chairman
George Cardoza
President
Kathryn McKenzie
Chief Financial Officer
Steven Ross
Chief Information Officer
Cynthia Dieter
Chief Accounting Officer
Denise Pedulla
General Counsel
Jennifer Balliet
Vice President
Address
12701 Commonwealth Dr Ste 9
Fort Myers, FL
33913-8626
United States